CymaBay Therapeutics scraps two studies of liver drug; shares plunge
(Reuters) – CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients,…
FDA approves Global Blood Therapeutics sickle cell disease drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to treat sickle cell disease in adults and children 12…
Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ
FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo (Reuters) – Swiss drugmaker Novartis AG…
Roche tests ‘brain shuttle’ in humans in Alzheimer’s project
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Roche is testing its “brain…
Roche sets sights on Novartis, Biogen as SMA trial hits target
FILE PHOTO: Roche tablets are seen positioned in front of a displayed Roche logo in this photo illustration January 22, 2016. REUTERS/Dado Ruvic ZURICH (Reuters) – Roche’s bid to rival…
Amgen posts higher biosimilar sales, ends neuroscience program
(Reuters) – Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall…
Two charities to pay $6 million to resolve U.S. pharma kickback probe
BOSTON (Reuters) – Two charities will pay $6 million to resolve claims they operated as pass-throughs for seven pharmaceutical companies to pay kickbacks to Medicare patients using their high-priced medications,…
FDA approves Alexion’s Ultomiris for another rare blood disease
(Reuters) – The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc’s treatment for a second rare blood disorder, the company said. The treatment, Ultomiris, has already been…
SEC freezes assets of 18 traders over alleged manipulation
WASHINGTON (Reuters) – U.S. authorities said on Wednesday it has obtained an asset freeze against 18 traders, who are primarily China-based, over an international market manipulation scheme that has reaped…
Lilly’s pancreatic cancer treatment fails late-stage study
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg,…